Research suggests that wild yam and its bioactive compounds, particularly diosgenin and dioscin, show some biologically relevant interactions with hormonal pathways, though the available evidence comes entirely from preclinical sources including animal studies, plant genomics research, and cell culture experiments, with no human clinical trials represented in this body of literature. Studies indicate that diosgenin biosynthesis in yam plants is regulated through complex genetic and epigenetic mechanisms, and that dioscin may exert phytoestrogenic effects in animal models of postmenopausal cardiovascular disease by interacting with estrogen receptor pathways, reducing plaque formation and oxidative stress in ovariectomized mice fed a high-fat diet. Additional preclinical work found that yam cell culture preparations improved metabolic markers in obese rats, with effects on blood glucose and cholesterol that researchers compared favorably to a prescription reference drug, though the translation of these findings to human hormonal health remains entirely unestablished. The overall direction of this evidence is mixed to neutral, reflecting genuine biological activity at the molecular and animal level, but the absence of human trials means no conclusions can be drawn about whether consuming wild yam produces meaningful hormonal effects in people.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| The origin and evolution of the diosgenin biosynthetic pathway in yam. | Other | 2021 | Mixed | 72 |
| Genome-wide methylation, transcriptome and characteristic metabolites reveal ... | Other | 2024 | Neutral | 67 |
| The Hypoglycemic and Hypocholesterolemic Activity of Dioscorea deltoidea, Tri... | Other | 2023 | Mixed | 62 |
| Association mapping of plant sex and cross-compatibility related traits in wh... | Other | 2022 | Neutral | 57 |
| Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/- mic... | Other | 2019 | Mixed | 52 |